Valuation: Star Scientific, Inc.

Market Cap 153K 134K 123K 115K 218K 14.61M 221K 1.48M 575K 7.18M 576K 563K 24.74M P/E 2014
-0.87x
P/E 2015 -1.04x
Enterprise Value 20.01M 17.49M 16.08M 14.98M 28.42M 1.91B 28.85M 193M 75.03M 937M 75.11M 73.5M 3.23B EV / Sales 2014
-
EV / Sales 2015 -
Free-Float
100%
Yield 2014 *
-
Yield 2015 -
Change 5-day change 1-year change 3-year change Capi.($)
-1.03%-2.08%+55.83%+160.00% 1,082B
-2.01%-0.14%+66.25%+59.74% 633B
-2.08%+0.61%+36.36%+86.41% 461B
-2.79%+1.37%+31.00%+23.05% 338B
-2.93%-1.65%+37.62%+36.15% 299B
-2.24%-0.87%+28.16%+42.69% 291B
-1.77%+1.97%-27.22%-40.66% 222B
-2.88%+0.77%+24.02%+62.94% 202B
-1.96%+1.99%+15.26%+68.99% 163B
Average -2.19%+4.45%+29.70%+55.48% 410.27B
Weighted average by Cap. -1.93%+5.43%+40.73%+80.40%

Financials

2014 2015
Net sales - -
Net income -38.52M -33.67M -30.94M -28.84M -54.71M -3.67B -55.54M -371M -144M -1.8B -145M -141M -6.21B -6.84M -5.98M -5.5M -5.13M -9.72M -652M -9.87M -66.02M -25.66M -320M -25.69M -25.14M -1.1B
Net Debt -45K -39.34K -36.15K -33.7K -63.92K -4.28M -64.89K -434K -169K -2.11M -169K -165K -7.26M 19.86M 17.36M 15.95M 14.87M 28.2M 1.89B 28.63M 192M 74.45M 929M 74.54M 72.93M 3.2B
Logo Star Scientific, Inc.
Rock Creek Pharmaceuticals Inc is a United States-based pharmaceutical development company. The Company is focused on the discovery, development and commercialization of therapies for chronic inflammatory disease and neurologic disorders. Its activities are focused on its lead compound, anatabine citrate (anatabine). Anatabine is a small molecule, cholinergic agonist, which exhibits anti-inflammatory pharmacological characteristics. The Company focuses on dermatological skin diseases, such as psoriasis, eczema and rare or orphan skin disorders, using its formulations of anatabine.
Employees
-